Ana P. Castaño

3 ta ish

Harvard University

1. CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma

   Bryan D. Choi, Xiaoling Yu, Ana P. Castaño +14

   MaqolaOAOchiq kirish20192 iqtibos

   ABIABI:AkademIndex/2026.other.020532

2. Mechanisms in photodynamic therapy: part one—photosensitizers, photochemistry and cellular localization

   Ana P. Castaño, Tatiana N. Demidova, Michael R. Hamblin

   MaqolaOAOchiq kirish20042 iqtibos

   ABIABI:AkademIndex/2026.other.082076

3. Photodynamic therapy and anti-tumour immunity

   Ana P. Castaño, Paweł Mróz, Michael R. Hamblin

   Sharh maqola20062 iqtibos

   ABIABI:AkademIndex/2026.other.596495